TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Birka BioBridges AB
Closing information (x1000 EUR)
| Closing information | 2024/03 | 2023/03 | 2022/03 |
| Turnover |
104
|
7
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
42
|
2
|
0 |
| EBITDA |
42
|
2
|
0 |
| Total assets |
80
|
7
|
4 |
| Current assets |
37
|
7
|
4 |
| Current liabilities |
38
|
2
|
0 |
| Equity capital |
40
|
5
|
3 |
| - share capital |
5
|
5
|
6 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Solvency |
50.0%
|
71.4%
|
75.0% |
| Turnover per employee |
104
|
7 | |
| Profit as a percentage of turnover |
40.4%
|
28.6% | |
| Return on assets (ROA) |
52.5%
|
28.6%
|
0% |
| Current ratio |
97.4%
|
350.0% | |
| Return on equity (ROE) |
105.0%
|
40.0%
|
0% |
| Change turnover |
98
|
7
|
0 |
| Change turnover % | 1504% | ||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.